Product References

Innovative Research is excited to share our top research products so far in the year 2024. These products are being purchased by other scientists like you, and are reflective of trends in current research. All of our products are designed to provide reliable, high-quality results. Take a look below to see what’s trending now. Single Donor Human Whole Blood K2 EDTA Our Single Donor Human Whole Blood K2 EDTA enables the preservation of blood samples for various laboratory analyses while maintaining sample stability, cell morphology, and compatibility with a wide range of laboratory tests. Additionally, we sell samples with specific...

Dive into the world of unparalleled genetic research with our diverse lineup of E. coli competent cells, meticulously designed to cater to a wide range of scientific endeavors. Whether you're conducting routine cloning, subcloning, protein production, or specialized applications, our strains are tailored to meet your needs with precision and efficiency. DH5α: The go-to strain for routine cloning, offering exceptional insert and plasmid stability thanks to its recA1 and endA1 mutations, and supports blue/white screening. HB101: Achieve high efficiency in cloning and subcloning, ideal when α-complementation isn't a necessity for your blue/white screening processes. JM101: Perfect for subcloning and plasmid...

In the ever-evolving landscape of molecular biology, precision tools are essential for elucidating complex biological processes. Specifically, when looking at scientific advancement in the field of diagnostic development, the role of specific monoclonal antibodies in understanding and manipulating biological processes cannot be overstated. Innovative Research offers a suite of monoclonal antibodies, including an array of PAI-1 monoclonals, designed to empower researchers in their quest for scientific discovery.   What is PAI-1? Plasminogen Activator Inhibitor-1 (PAI-1) is a protein that functions as the principal inhibitor of tissue plasminogen activator and urokinase plasminogen activator, two enzymes responsible for the conversion of plasminogen...

In a groundbreaking study, researchers have pioneered a diabetes treatment that could revolutionize the management of type 1 diabetes. By transplanting genetically engineered hypoimmune pseudo-islets into diabetic non-human primates, the team achieved insulin independence without necessitating immunosuppression, marking a significant advancement in diabetes research. Notably, Molecular Innovations' Total Rhesus IgG ELISA Kit played a crucial role in this research, underscoring the company's commitment to supporting scientific breakthroughs.   The Study's Significance and Methodology The study demonstrates a novel approach to diabetes treatment, utilizing hypoimmune pseudo-islets to circumvent the challenges associated with allogeneic transplantation and immunosuppression. This method not only promises...

In the dynamic landscape of medical research, SAR443809 emerges as a promising candidate for the treatment of complement-mediated disorders. Complement-mediated disorders pose a significant challenge in healthcare, marked by the immune system erroneously targeting healthy cells. Central to these disorders is the complement alternative pathway, an integral part of our immune response. When dysregulated, it can precipitate severe and potentially fatal conditions. This groundbreaking study unveils the potential of a humanized IgG4 monoclonal antibody, specifically designed to selectively inhibit the complement alternative pathway, thereby opening new therapeutic avenues for patients globally. Key Insights from Recent Research SAR443809 distinguishes itself with...